Introduction
A symmetrical pattern of involvement in some diseases, such as rheumatoid arthritis, is clinically so important that it is a feature of their diagnostic criteria. 1 Is this a statistical aberration secondary to the large number of joints involved, or are there underlying mechanisms to explain the symmetry? Insight comes from another in ammatory condition, psoriasis. Skin psoriasis and some of the arthritides associated with it affect the topographically precise contralateral side much more frequently than a mathematical model would predict if there was a random pattern of disease distribution. 2, 3 There are many other painful and in ammatory conditions that exhibit symmetry.
Complex regional pain syndrome (CRPS) has also been described as symmetrical in a substantial number of patients. Documented bilateral presenting symptoms have been noted to occur in about 5% of patients with CRPS. 4 However, detailed investigations, such as with technetium pertechnetate bone scanning, demonstrate that a symmetrical involvement may occur more commonly than clinical symptoms suggest. 5 Osteoarthritis is a painful condition in which biomechanical factors are undoubtedly important. However, as in in ammatory arthritis, neurological lesions are protective against developing osteoarthritis 6 and a symmetrical distribution to the joints affected by osteoarthritis is also a feature. 7 Sympathetic ophthalmia is a rare bilateral granulomatous panuveitis that occurs days, months or years after a penetrating eye injury. The histopathology is characterized by diffuse choroidal thickening and lymphocytic in ltration, Symmetry is a cardinal feature of certain painful and in ammatory diseases, including rheumatoid arthritis and psoriasis. This symmetry does not occur by chance, but it is as yet unexplained. It has been hypothesized by this group and others that mechanisms of neurogenic in ammation could explain both this symmetrical distribution and the chronicity of these diseases. A recent review has demonstrated contralateral responses in the nervous system to unilateral neurological insults. These responses were topographically precise and stimulus speci c in nature. This article details similar responses that have been observed to in ammatory stimuli in animal models. The role of pro-in ammatory neuropeptides, such as substance P, in these pathways is discussed. The hypothesis could be tested in both animals and humans.
interrupted at multiple sites by collections of epithelioid cells and a few multinucleated giant cells, both containing pigment. The only way to prevent sympathetic ophthalmia is enucleation of the traumatized eye, and some reports suggest that this procedure, even after development of the disease, ameliorates its course. 8 There must be factors in the traumatized eye that in uence the prognosis of the 'sympathizing' eye. These are most likely to be hidden antigens, exposed at the time of trauma to trigger an autoimmune reaction, but other hypotheses could be put forward to explain the chronic destructive lymphocytic involvement, not dissimilar in appearance to another symmetrical disease, rheumatoid arthritis.
The improvement of imaging techniques, speci cally the use of magnetic resonance imaging (MRI), has yielded much more information. Minor neurological abnormalities, as detected by brain MRI scans enhanced by gadolinium diethylenetriaminepentaacetic acid and diffusion studies, were seen to predate contralateral plaque development in patients with active multiple sclerosis. 9 In testicular malignancy, the nonaffected testes of 21 patients were seen to have changes detected by gadolinium-enhanced MRI scans, which persisted for up to 45 months after orchidectomy. 10 All of this clinical evidence suggests that symmetrical patterns are not simply the product of a disease process that affects distant areas of the body in a nonrandom manner. There is order to the distribution of disease. This order is, however, unexplained.
A hypothesis has been proposed by this group and others that the symmetry of disease is neurologically mediated by the mechanisms of neurogenic in ammation. This pathophysiology contributes to the severity and chronicity of these diseases.
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Experimental evidence for the symmetrical spread of pain and in ammation
The nervous system is anatomically symmetrical, both peripherally and centrally. The two sides of the spinal column have generally been thought to function independently from each other. This is clearly not true. Koltzenburg et al. 13 have reviewed the literature detailing the various neuronal insults that result in contralateral identical responses.
The body has contralateral responses to neurological lesions, so does it have contralateral responses to in ammatory lesions? Numerous experimental observations in the rat hindpaw and monoarthritic lesions have provided evidence that such responses do occur (Tables 1 and 2 ).
These contralateral responses to ipsilateral in ammation are not artefactual. They have been described in different animal models, using different insults, and have produced a variety of responses observed in different laboratories. In some experiments, contralateral effects were documented even though they had not been postulated. For instance, some investigators used contralateral joints or hindpaws as controls and were surprised to nd changes. 16 
A nociceptive explanation for contralateral effects
There are three possible mechanisms to explain these contralateral responses: neurological, circulatory, or a combination of both routes. There is strong evidence to implicate the nervous system and reasons to suggest that the circulatory system is unlikely to be solely responsible; but some evidence suggests that the nervous system focuses circulation-dependent in ammatory responses.
Neuropeptide-containing unmyelinated bres are important in mediating contralateral responses. The response is abolished or attenuated if peripheral nerves are sectioned. 15, 28 If C bres are targeted selectively by using capsaicin or intrathecal substance P antagonists, then the response is also abolished. 15, 19, 34 Spinal cord compression also attenuates the contralateral response. 15 It is therefore unlikely that supraspinal control is essential for contralateral responses to occur, although these pathways are likely to in uence these responses.
The presence of such contralateral pathways is suggested both anatomically and electrophysiologically. Neurones, presumably nociceptive, that decussate in the spinal cord have been described in repeated histological studies. [35] [36] [37] These occur 37 Electrophysiological studies show sensory neurones with contralateral receptive elds. [38] [39] [40] Receptive elds from some nociceptive bres are seen to expand in the presence of in ammation from unilateral to bilateral in a topographically precise fashion.
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A circulatory explanation for contralateral effects
An alternative hypothesis is that the contralateral effect is mediated via the circulation as part of a systemic response. It is dif cult however to envisage how a circulatory factor could be so topographically speci c as to trigger a response in the contralateral knee, but not the hip or the ankle. 17, 19 Equally persuasive against a circulatory basis for these responses are experiments in There are however studies that demonstrate leucocytes unexpectedly traf cking to the contralateral joint after inducement of a monoarthritis. 41, 42 Methotrexate appears in the contralateral knee within one hour after it is injected intraarticularly. 43 It is unknown whether this is an anatomically speci c or a more generalized synovial response. Further evidence supporting the role of the nervous system in directing in ammatory responses comes from studies demonstrating the lateralization of T-cell responses in patients who have suffered a stroke. 44 It is therefore possible that a systemic in ammatory response could be targeted focally by a nervous system that upregulates local in ammatory responses.
Neuropeptides and in ammation: neurogenic in ammation
The role of neuropeptides in chronic disease has long been hypothesized. 11, 12 The role of neurogenic in ammation in psoriasis has been clearly shown in a photograph demonstrating resolution of part of a plaque after surgical severance of intercostal nerves. 45 Clinically, paralysed joints caused either by stroke or poliomyelitis, are spared in patients with rheumatoid arthritis and neurological compromise. [46] [47] [48] [49] Experimentally, by selectively lesioning C bres with capsaicin, in ammation in animal models of arthritis is attenuated. 50 Neuropeptides, such as substance P and calcitonin gene-related peptide (CGRP) have pro-in ammatory effects. They in uence vasodilation, extravasation, leucocyte mobilization and leucocyte-driven microbial destruction systems. 51, 52 The net effect of these properties is to 'upregulate' the in ammatory response and they are the peptides that cause the skin are wheal in axon re exes. It has been demonstrated that nerve bres (C and A delta bres) containing these neuropeptides are found in synovial joints and in an especially high concentration perivascularly. Some bres also extend deeper into joint synovium. 53 The dense innervation of joints with these bres provides anatomical evidence that neuropeptides are well positioned to in uence in ammatory responses there and could explain the presence of the histological ndings in patients with CRPS. 5 Systemic levels of CGRP are increased in patients with CRPS, 54 in whom the level of substance P in cerebrospinal uid has been shown to be about three times that of a matched control population. 55 Neuropeptide levels are increased in synovial uid taken from patients with rheumatic diseases. 56 Neuropeptides have also been shown to recruit leucocytes into the synovium. 57 Joints primed with neuropeptides mount larger in ammatory responses to pro-in ammatory substances such as histamine 58 or bradykinin. 19 In animal models, joints injected with neuropeptides develop more severe experimental arthritis. 59 Patients with chronic pain syndromes or rheumatoid arthritis show differences in nociceptive pathways when compared with normal control patients. The area of secondary hyperalgesia (de ned as increased pain that is distant from tissue injury) after topical capsaicin is larger in patients with rheumatoid arthritis than in normal controls. 60 Broadly speaking, this could be interpreted as an upregulation of in ammatory responses. At a higher level, cortical and subcortical changes have been observed 61 in patients with chronic pain, which are different to those in people with rheumatoid arthritis and normal controls.
Testing the hypothesis
Anatomical and electrophysiological studies could be used further to elucidate transmedian pathways in spinal segments in both animals and humans. Animal models could also be developed further to understand the in uence of neurogenic in ammation on the symmetry of arthritis. These could include rats treated with capsaicin neonatally to reduce signi cantly the number of neuropeptide-containing C bres.
In humans, hyperalgesia and early in ammation can be safely and reliably induced by using capsaicin, histamine, or thermal burns, and can be measured by standard psychophysical techniques. 62 Skin blood ow, a marker of in ammatory response, can be assessed by thermographic and laser Doppler imaging. Cellular in ammatory response can be assessed histologically and by using immunocytochemical methods. Stable and reliable models of contralateral responses need to be developed. Candidate models include contralateral vasodilatation in response to topical or intradermal capsaicin. Contralateral responses to in ammatory stimuli could therefore be assessed in patients with in ammatory diseases and in normal controls. Physiological studies could then be performed further to understand the mechanisms of contralateral responses, and pharmacological compounds aimed at blocking them could be tested. Once perfected, these techniques could become a novel therapeutic strategy for use in in ammatory conditions.
Conclusion
Symmetry occurs frequently in medical practice. A nociceptive pathway has been proposed to explain this. Patients with chronic painful or in ammatory conditions demonstrate different peripheral neurological responses compared with normal controls. Neurogenic in ammation may therefore explain the symmetry seen in these conditions. Compounds that stabilize these nociceptive pathways to prevent neurogenic in ammation could alter signi cantly the prognosis of these diseases and thereby offer new therapies.
